Stem Cells Market And Technologies

2009-2015

Product Code ARM00003
Publication Date July 2010
Publisher Axis Research Mind
Product Type Report
Pages 472
ISBN Number not applicable
Change currency
PDF £2,750.00 €3,312 $4,348 BUY >
Order by fax
Ask a question about this product > Receive product alerts > Call now +44 20 7060 7474

Stem Cells Market And Technologies

2009-2015

Supported by Cord Blood Banking Technology, global stem cells market is expected to reach US$63.8 billion by 2015, with a CAGR of 24.2% during 2010-2015.

The 'Stem Cells Market and Technologies, 2009-2015' reviews the latest trends in the stem cells market with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science and healthcare sector investments. The study reveals profitable investment strategies for stem cell banks, stem cells R&D organizations, pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations.

The report primarily focuses on:

  • Stem cell market trends in emerging markets
  • Advancements in the technological space
  • Demand of the market segments (by-region)
  • Key growth areas and market size
  • Competitors' edge

The analysis primarily deals with major stem cells product segments and stem cells technologies, detailing region-wise growth rates. The stem cells product segments include adult stem cells, cord blood stem cells, embryonic stem cells and others.

The major stem cells technologies discussed in the report are:

  • Cell Based Technologies
  • Cord Blood Banking
  • Cryopreservation
  • Stem Cell Banking
  • Stem Cell Characterization
  • Stem Cell Drug Discovery
  • Stem Cell Production
  • Stem Cell Transplants
  • Xenotransplantation and
  • Others (Blood Transfusion and Molecular Biology and Others)

The report centers on major current market trends, estimates and forecasts for the period 2009-2015. More than 500 leading market players are identified and 37 key companies that project improved market activities in the near future are profiled. The report consists of 321 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed which gives a deep insight into the growth perspectives of the market.

The region wise distribution of the market covers North America (USA, Canada and Mexico), Europe (Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom and Rest of Europe), Asia-Pacific (Australia, China, India, Japan, South Korea and Rest of Asia-Pacific), Latin America (Argentina and Brazil) and Rest of the World (Columbia, Middle East, South Africa and Rest of Rest of World). Incorporating the recession impacts on the industry, the market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years. Anticipating a protracted economic recovery towards to 2011 and based on the CAGR estimates and growth potential, we have forecasted the market size figures for the next five years.

New trends in stem cell technologies realized multidisciplinary research consortia among academic, medical, government and industry partners. Anticipating a boom in technological space, the consortia members are expected to be benefitted in the application front and in practicing stem-cell technology in life science arena.

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates. Estimates have incorporated recessionary impact on the stem cells industry.

Global Market Watch

Global stem cells market is forecasts to reach US$63.8 billion by 2015 from an estimated value of US$21.5 billion in 2010, exhibiting a triple fold growth rate during the period 2010-2015. Our study on the stem cell technologies reveals that cord blood banking and xenotransplantation are expected to lead the technologies during 2010-2015. Drug discovery and stem cell transplantation techniques are also expected to ground in the upcoming years.

The stem cell market is expected to witness a substantial growth in the upcoming years, with a CAGR of 24.2%, globally. Although North America will likely post highest market value by 2015, Asian economies are expected to maintain large CAGR of 27 percent during 2010-2015, could fetch improved industry investments in the region in comparison with North America and Europe.

Improving health consciousness in Europe will likely maintain the Union competent with Asia-Pacific/North America. India possesses the potential to occupy the leading position in stem cell market growth with a CAGR exceeding 28 percent through 2015. Spain, Sweden and Germany are anticipated to top among the European countries with an annual compounded growth rate of more than 27 percent respectively through 2010-2015. Latin American countries will not likely experience a massive growth rate in comparison with North American/Asian economies. Overall, emerging economies could tag higher growth rate stem cells market in the next few years.

Contents

  • Some companies mentioned out of 500 companies
    • AASTROM BIOSCIENCES, INC.
    • ACORDA THERAPEUTICS, INC.
    • ADVANCED CELL TECHNOLOGY, INC.
    • AFFYMETRIX, INC
    • ALPHA CORD, INC
    • ANGIOBLAST SYSTEMS, INC.
    • BIOHEART, INC
    • BOEHRINGER-INGELHEIM GMBH
    • CELL THERAPEUTICS, INC.
    • CELLS4LIFE LTD.
    • CORCELL, INC.
    • CORD BLOOD REGISTRY
    • CORDLIFE LTD.
    • CRYOCORD SDN. BHD.
    • And many more...
  • 1. Report Focus
    • A. Introduction
    • Functions Of Stem Cells
    • Stem Cell Applications
    • Stem Cell Milestones
    • Definition And Importance
    • Stem Cell Debate
    • Conclusion
  • 1. Stem Cells Product Categories Chosen In The Report
    • B. Stem Cells – The Beginning Of All Blood Cells
    • Adult Stem Cells
    • Embryonic Stem Cells
    • Umbilical Cord Blood Stem Cells
    • Totipotent Stem Cells
    • Pluripotent Stem Cells
    • Multipotent Stem Cells
    • Oligopotent Stem Cells
    • Unipotent Stem Cells
  • 2. Differential Potential Ranges From Totipotent Stem Cells To Nullipotent Cells
    • Induced Pluripotent Stem Cells (Ipscs)
    • Disease Detection
    • Challenges To Culture
    • Standard Guideline For Ips Technology
    • C. Advances In Stem Cell Research
  • 3. Stem Cells Banking Storage Price Structure Around The World
    • D. Similarities And Differences Between Embryonic And Adult Stem Cells
    • E. The Controversy On Stem Cell
    • Stem Cells Background
    • Outlook
    • Argument
    • Proper Use
    • Transcendence
    • The Beginning
    • Life Importance
    • F. A Review On Adult Stem Cells
    • The Role Of Adult Stem Cells In Tissue Repair
    • Adult Stem Cells And Cancer
    • First Transplantation Of Human Organ Grown From Adult Stem Cells
    • Advantages Of Adult Bm Cells Transplantation In Cardiology
    • Conclusion
    • G. A Review On Embryonic Stem Cells
    • History
    • Major Support To Embryonic Stem Cell Research
    • A Combined Effort
    • Confusing Legislation
    • Rewarding The Deserving
    • Governmental Policy In Different Regions
    • Americas
    • United States
    • Europe
    • Asia-Pacific
    • Africa
    • Embryonic Stem Cell Research 'Controversy'
    • Creation Of Embryonic Characteristics From Human Umbilical Cord Blood
    • Human Embryonic Stem Cells (Hes) Classification And Differentiation
    • Origin, Expansion And Applications Of Human Embryonic Stem Cells
    • Advantages Of Es Cell Transplantation In Cardiology
    • H. A Review On Cord Blood Stem Cells
    • Enhancements
    • Uses Of Cord Blood Banking
    • Focus And Scope Of Companies Into Cord Blood Stem Cells
    • Bmsn (Bio-Matrix Scientific Group, Inc.)
    • Medistem Inc
    • Cryo-Cell International, Inc
    • Glance At U.S Private Family Banks
    • Cord Blood America, Inc
    • Viacell, Inc
    • Other Companies
    • Progress In Cord Blood Collection, Processing And Transplantation
    • Tight Measures And Certifications
    • Test On Stem Cells From Blood Cord
  • 4. Stem Cells Companies In Different Countries With Their Number Of Transplants
    • I. Stem Cells Technology
    • Automated Stem Cell Culture With Greater Consistency
    • Restrictions Observed In The Manual Cultivation
    • Automation Solution
    • Consistency And Reproducibility
    • J. Stem Cells In Various Technologies
    • Cell Based Technologies
    • A) Heart Disease Or Ailment
    • B) Diabetes
    • C) Stem Cell Therapy Or Treatment For Diabetes
    • D) Parkinson's Disease
    • Cord Blood Banking
    • Public Banks
    • Private Banks
    • Cryopreservation
    • Stem Cell Banking
    • Stem Cell Characterization
    • Stem Cell Drug Discovery
    • Embryonic Stem Cells As A Source Of Models For Drug Discovery
    • Stem Cell Production
    • New Way Of Producing Stem Cells Found
    • Stem Cell Transplants
  • 5. List Of Applications For Stem Cell Transplantation
    • Xenotransplantaion
    • Blood Transfusion
    • Molecular Biology
    • Ii. Market Analysis
    • Stem Cells Market And Technologies – Snapshot
    • A. Stem Cells Market And Technologies – Segmentation
  • 6. Global Stem Cells - Segmentation By Products & By Technologies
  • 7. Stem Cells – Global Current Trends, Estimates & Forecasts - (2009-2015, In Usd$ Million)
  • 8. Stem Cells - Geographic Region Current Trends, Estimates & Forecasts For
    • North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 9. Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value - (2009 - 2012 - 2015)
    • B. Stem Cells – By Country
    • North America
  • 10. Stem Cells - Usa, Canada And Mexico - (2009-2015, In Usd$ Million)
  • 11. Stem Cells - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
    • Europe
  • 12. Stem Cells - Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 13. Stem Cells - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 14. Stem Cells - Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 15. Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 16. Stem Cells - Argentina And Brazil - (2009-2015, In Usd$ Million)
  • 17. Stem Cells - % Of Argentina And Brazil Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 18. Stem Cells - Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 19. Stem Cells - Columbia, Middle East, South Africa And Rest Of Rest Of World - % Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • C. Stem Cells – Product Segments
  • 20. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic
    • Stem Cells And Others For Global Current Trends, Estimates & Forecasts - (2009-2015, In Usd$ Million)
  • 21. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Global Market Value - (2009 - 2012 - 2015)
    • C1. Stem Cell Product Segments - Geographic Region
    • Adult Stem Cells
  • 22. Stem Cell Products - Adult Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 23. Stem Cell Products - Adult Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • 24. Stem Cell Products - Adult Stem Cells For Usa, Canada And Mexico - (2009-2015, In Usd$ Million)
  • 25. Stem Cell Products - Adult Stem Cells - % Of Usa, Canada And Mexico
    • Market Value - (2009 - 2012 - 2015)
    • Europe
  • 26. Stem Cell Products - Adult Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 27. Stem Cell Products - Adult Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe
    • Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 28. Stem Cell Products - Adult Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 29. Stem Cell Products - Adult Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 30. Stem Cell Products - Adult Stem Cells For Argentina And Brazil - (2009-2015, In Usd$ Million)
  • 31. Stem Cell Products - Adult Stem Cells - % Of Argentina And Brazil
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 32. Stem Cell Products - Adult Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 33. Stem Cell Products - Adult Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • Cord Blood Stem Cells
  • 34. Stem Cell Products - Cord Blood Stem Cells By Geographic Region
    • Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 35. Stem Cell Products - Cord Blood Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • 36. Stem Cell Products - Cord Blood Stem Cells For Usa, Canada And Mexico - (2009-2015, In Usd$ Million)
  • 37. Stem Cell Products - Cord Blood Stem Cells - % Of Usa, Canada And Mexico
    • Market Value - (2009 - 2012 - 2015)
    • Europe
  • 38. Stem Cell Products - Cord Blood Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 39. Stem Cell Products - Cord Blood Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe
    • Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 40. Stem Cell Products - Cord Blood Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 41. Stem Cell Products - Cord Blood Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 42. Stem Cell Products - Cord Blood Stem Cells For Argentina And Brazil - (2009-2015, In Usd$ Million)
  • 43. Stem Cell Products - Cord Blood Stem Cells - % Of Argentina And Brazil
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 44. Stem Cell Products - Cord Blood Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 45. Stem Cell Products - Cord Blood Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World
    • Market Value - (2009 - 2012 - 2015)
    • Embryonic Stem Cells
  • 46. Stem Cell Products - Embryonic Stem Cells By Geographic Region
    • Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 47. Stem Cell Products - Embryonic Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • 48. Stem Cell Products - Embryonic Stem Cells For Usa And Canada - (2009-2015, In Usd$ Million)
  • 49. Stem Cell Products - Embryonic Stem Cells - % Of Usa And Canada
    • Market Value - (2009 - 2012 - 2015)
    • Europe
  • 50. Stem Cell Products - Embryonic Stem Cells For Belgium, Denmark, France, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 51. Stem Cell Products - Embryonic Stem Cells - % Of Belgium, Denmark, France, Greece, Spain, Sweden, United Kingdom And Rest Of Europe
    • Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 52. Stem Cell Products - Embryonic Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 53. Stem Cell Products - Embryonic Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific
    • Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 54. Stem Cell Products - Embryonic Stem Cells For Brazil - (2009-2015, In Usd$ Million)
    • Rest Of World
  • 55. Stem Cell Products - Embryonic Stem Cells For Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 56. Stem Cell Products - Embryonic Stem Cells - % Of Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • Other Stem Cells
  • 57. Stem Cell Products - Other Stem Cells By Geographic Region Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 58. Stem Cell Products - Other Stem Cells - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • 59. Stem Cell Products - Other Stem Cells For Usa, Canada And Mexico - (2009-2015, In Usd$ Million)
  • 60. Stem Cell Products - Other Stem Cells - % Of Usa, Canada And Mexico
    • Market Value - (2009 - 2012 - 2015)
    • Europe
  • 61. Stem Cell Products - Other Stem Cells For Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 62. Stem Cell Products - Other Stem Cells - % Of Denmark, France, Germany, Spain, Sweden, United Kingdom And Rest Of Europe
    • Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 63. Stem Cell Products - Other Stem Cells For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 64. Stem Cell Products - Other Stem Cells - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 65. Stem Cell Products - Other Stem Cells For Argentina And Brazil - (2009-2015, In Usd$ Million)
  • 66. Stem Cell Products - Other Stem Cells - % Of Argentina And Brazil
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 67. Stem Cell Products - Other Stem Cells For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 68. Stem Cell Products - Other Stem Cells - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • C2. Stem Cells – By Product
    • North America
  • 69. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem
    • Cells And Others For North America - (2009-2015, In Usd$ Million)
  • 70. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of North American
    • Market Value - (2009 - 2012 - 2015)
    • United States Of America
  • 71. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells,Embryonic Stem
    • Cells And Others For The United States Of America - (2009-2015, In Usd$ Million)
  • 72. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of The United States Of America
    • Market Value - (2009 - 2012 - 2015)
    • Canada
  • 73. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Canada - (2009-2015, In Usd$ Million)
  • 74. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells
    • And Others - % Of Canadian Market Value - (2009 - 2012 - 2015)
    • Mexico
  • 75. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others
    • For Mexico - (2009-2015, In Usd$ Million)
  • 76. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of Mexican Market Value - (2009 - 2012 - 2015)
    • Europe
  • 77. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem
    • Cells And Others For Europe - (2009-2015, In Usd$ Million)
  • 78. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of European
    • Market Value - (2009 - 2012 - 2015)
    • Belgium
  • 79. Stem Cell Products - Embryonic Stem Cells For Belgium - (2009-2015, In Usd$ Million)
    • Denmark
  • 80. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Denmark - (2009-2015, In Usd$ Million)
  • 81. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Danish
    • Market Value - (2009 - 2012 - 2015)
    • France
  • 82. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For France - (2009-2015, In Usd$ Million)
  • 83. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of French Market Value - (2009 - 2012 - 2015)
    • Germany
  • 84. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others
    • For Germany - (2009-2015, In Usd$ Million)
  • 85. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of German Market Value - (2009 - 2012 - 2015)
    • Greece
  • 86. Stem Cell Products - Embryonic Stem Cells For Greece - (2009-2015, In Usd$ Million)
    • Spain
  • 87. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Spain - (2009-2015, In Usd$ Million)
  • 88. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Spanish Market Value - (2009 - 2012 - 2015)
    • Sweden
  • 89. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Sweden - (2009-2015, In Usd$ Million)
  • 90. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Swedish
    • Market Value - (2009 - 2012 - 2015)
    • The United Kingdom
  • 91. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For The United Kingdom - (2009-2015, In Usd$ Million)
  • 92. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of The United Kingdom
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of Europe
  • 93. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Europe - (2009-2015, In Usd$ Million)
  • 94. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Europe
    • Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 95. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Asia-Pacifc - (2009-2015, In Usd$ Million)
  • 96. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Asia-Pacific
    • Market Value - (2009 - 2012 - 2015)
    • Australia
  • 97. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Australia - (2009-2015, In Usd$ Million)
  • 98. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem
    • Cells And Others - % Of Australian Market Value - (2009 - 2012 - 2015)
    • China
  • 99. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For China - (2009-2015, In Usd$ Million)
  • 100. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic
    • Stem Cells And Others - % Of Chinese Market Value - (2009 - 2012 - 2015)
    • India
  • 101. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For India - (2009-2015, In Usd$ Million)
  • 102. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Indian Market Value - (2009 - 2012 - 2015)
    • Japan
  • 103. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Japan - (2009-2015, In Usd$ Million)
  • 104. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic
    • Stem Cells And Others - % Of Japanese Market Value - (2009 - 2012 - 2015)
    • South Korea
  • 105. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For South Korea - (2009-2015, In Usd$ Million)
  • 106. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of South Korean
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of Asia-Pacific
  • 107. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 108. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Asia-Pacific
    • Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 109. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic
    • Stem Cells And Others For Latin America - (2009-2015, In Usd$ Million)
  • 110. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells
    • And Others - % Of Latin American Market Value - (2009 - 2012 - 2015)
    • Argentina
  • 111. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others For
    • Argentina - (2009-2015, In Usd$ Million)
  • 112. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, And Others - % Of Argentina Market Value - (2009 - 2012 - 2015)
    • Brazil
  • 113. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Brazil - (2009-2015, In Usd$ Million)
  • 114. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic
    • Stem Cells And Others - % Of Brazilian Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 115. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of World - (2009-2015, In Usd$ Million)
  • 116. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of World
    • Market Value - (2009 - 2012 - 2015)
    • Columbia
  • 117. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others
    • For Columbia - (2009-2015, In Usd$ Million)
  • 118. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells And Others - % Of Columbian Market Value - (2009 - 2012 - 2015)
    • Middle East
  • 119. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Middle East - (2009-2015, In Usd$ Million)
  • 120. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Middle East
    • Market Value - (2009 - 2012 - 2015)
    • South Africa
  • 121. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For South Africa - (2009-2015, In Usd$ Million)
  • 122. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of South African
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of Rest Of The World
  • 123. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others For Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 124. Stem Cell Products - Adult Stem Cells, Cord Blood Stem Cells, Embryonic Stem Cells And Others - % Of Rest Of Rest Of World
    • Market Value - (2009 - 2012 - 2015)
    • D. Stem Cells – Technologies
  • 125. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell
    • Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Global Current Trends, Estimates & Forecasts - (2009-2015, In Usd$ Million)
  • 126. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell
    • Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Global Market Value - (2009 - 2012 - 2015)
    • D1. Stem Cells - Technologies - Geographic Region
    • Cell Based Technologies
  • 127. Stem Cell Technologies - Cell Based Technologies By Geographic Region
    • Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 128. Stem Cell Technologies - Cell Based Technologies - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • 129. Stem Cell Technologies - Cell Based Technologies For Usa, Canada And Mexico - (2009-2015, In Usd$ Million)
  • 130. Stem Cell Technologies - Cell Based Technologies - % Of Usa, Canada And Mexico Market Value - (2009 - 2012 - 2015)
    • Europe
  • 131. Stem Cell Technologies - Cell Based Technologies For Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe - (2009-2015, In Usd$ Million)
  • 132. Stem Cell Technologies - Cell Based Technologies - % Of Belgium, Denmark, France, Germany, Greece, Spain, Sweden, United Kingdom And Rest Of Europe Market Value - (2009 - 2012 - 2015)
    • Asia-Pacific
  • 133. Stem Cell Technologies - Cell Based Technologies For Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific - (2009-2015, In Usd$ Million)
  • 134. Stem Cell Technologies - Cell Based Technologies - % Of Australia, China, India, Japan, South Korea And Rest Of Asia-Pacific
    • Market Value - (2009 - 2012 - 2015) 187(2009-2015, In Usd$ Million)
  • 136. Stem Cell Technologies - Cell Based Technologies - % Of Argentina And Brazil
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of World
  • 137. Stem Cell Technologies - Cell Based Technologies For Columbia, Middle East, South Africa And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 138. Stem Cell Technologies - Cell Based Technologies - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • Cord Blood Banking
  • 139. Stem Cell Technologies - Cord Blood Banking By Geographic Region
    • Current Trends, Estimates & Forecasts For North America, Europe, Asia-Pacific, Latin America And Rest Of World - (2009-2015, In Usd$ Million)
  • 140. Stem Cell Technologies - Cord Blood Banking - % Of North America, Europe, Asia-Pacific, Latin America And Rest Of World Market Value By
    • Geographic Region - (2009 - 2012 - 2015)
    • North America
  • ...
  • 245. Stem Cell Technologies - Others For Columbia, Middle East, South Africa
    • And Rest Of Rest Of World - (2009-2015, In Usd$ Million)
  • 246. Stem Cell Technologies - Others - % Of Columbia, Middle East, South Africa And Rest Of Rest Of World Market Value - (2009 - 2012 - 2015)
    • D2. Stem Cells – By Technologies
    • North America
  • 247. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others
    • For North America - (2009-2015, In Usd$ Million)
  • 248. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of North American Market Value - (2009 - 2012 - 2015)
    • United States Of America
  • 249. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For The United States Of America - (2009-2015, In Usd$ Million)
  • 250. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of The United States Of America
    • Market Value - (2009 - 2012 - 2015)
    • Canada
  • 251. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Canada - (2009-2015, In Usd$ Million)
  • 252. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Canadian Market Value - (2009 - 2012 - 2015)
    • Mexico
  • 253. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Mexico - (2009-2015, In Usd$ Million)
  • 254. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Mexican Market Value - (2009 - 2012 - 2015)
    • Europe
  • 255. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Europe - (2009-2015, In Usd$ Million)
  • 256. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of European Market Value - (2009 - 2012 - 2015)
    • Belgium
  • 257. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Belgium - (2009-2015, In Usd$ Million)
  • 258. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Belgium Market Value - (2009 - 2012 - 2015)
    • Denmark
  • 259. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Denmark - (2009-2015, In Usd$ Million)
  • 260. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Danish
    • Market Value - (2009 - 2012 - 2015)
    • France
  • 261. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For France - (2009-2015, In Usd$ Million)
  • 262. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of French Market Value - (2009 - 2012 - 2015)
    • Germany
  • ...
  • 269. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Sweden - (2009-2015, In Usd$ Million)
  • 270. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Swedish Market Value - (2009 - 2012 - 2015)
    • The United Kingdom
  • 271. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Othersfor The United Kingdom - (2009-2015, In Usd$ Million)
  • 272. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of The United Kingdom
    • Market Value - (2009 - 2012 - 2015)
    • Rest Of Europe
  • ...
  • 288. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Rest Of Asia-Pacific Market Value - (2009 - 2012 - 2015)
    • Latin America
  • 289. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Latin America - (2009-2015, In Usd$ Million)
  • 290. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Latin American
    • Market Value - (2009 - 2012 - 2015)
    • Argentina
  • 291. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others For Argentina - (2009-2015, In Usd$ Million)
  • 292. Stem Cell Technologies - Cell Based Technologies, Cord Blood Banking, Cryopreservation, Stem Cell Banking, Stem Cell Characterization, Stem Cell Drug Discovery, Stem Cell Production, Stem Cell Transplants, Xenotransplantation And Others - % Of Argentina Market Value - (2009 - 2012 - 2015)
    • Brazil
  • ...
  • 305. Global Stem Cells Market Value - % Growth Rate Forecasts - (2009-2015)
    • Stem Cells - Product Segments
    • Global Stem Cells Product Segments Market Growth Rates
  • 306. Global Stem Cells - Product Segments - % Growth Rate Forecasts - (2009-2015)
    • Adult Stem Cells
    • Market Growth Rates For Adult Stem Cells
  • 307. Global Adult Stem Cells - % Growth Rate Forecasts - (2009-2015)
    • Cord Blood Stem Cells
    • Market Growth Rates For Cord Blood Stem Cells
  • 308. Global Cord Blood Stem Cells - % Growth Rate Forecasts - (2009-2015)
    • Embryonic Stem Cells
    • Market Growth Rates For Embryonic Stem Cells
  • 309. Global Embryonic Stem Cells - % Growth Rate Forecasts - (2009-2015)
    • Stem Cells – Technologies
    • Global Stem Cell Technologies Market Growth Rates
  • 310. Global Stem Cells - Technologies - % Growth Rate Forecasts - (2009-2015)
    • Cord Blood Banking
    • Market Growth Rates For Cord Blood Banking
  • 311. Global Cord Blood Banking - % Growth Rate Forecasts - (2009-2015)
    • Stem Cell Characterization
    • Market Growth Rates For Stem Cell Characterization
  • 312. Global Stem Cell Characterization - % Growth Rate Forecasts - (2009-2015)
    • Xenotransplantation
    • Market Growth Rates For Xenotransplantation
  • 313. Global Xenotransplantation - % Growth Rate Forecasts - (2009-2015)
    • Stem Cell Drug Discovery
    • Market Growth Rates For Stem Cell Drug Discovery
  • 314. Global Stem Cell Drug Discovery - % Growth Rate Forecasts - (2009-2015)
    • Stem Cell Transplants
    • Market Growth Rates For Stem Cell Transplants
  • 315. Global Stem Cell Transplants - % Growth Rate Forecasts - (2009-2015)
    • Stem Cell Production
    • Market Growth Rates For Stem Cell Production
  • 316. Global Stem Cell Production - % Growth Rate Forecasts - (2009-2015)
    • Stem Cell Banking
    • Market Growth Rates For Stem Cell Banking
  • 317. Global Stem Cell Banking - % Growth Rate Forecasts - (2009-2015)
    • Cryopreservation
    • Market Growth Rates For Cryopreservation
  • 318. Global Cryopreservation - % Growth Rate Forecasts - (2009-2015)
    • Cell Based Technologies
    • Market Growth Rates For Cell Based Technologies
  • 319. Global Cell Based Technologies - % Growth Rate Forecasts - (2009-2015)
    • F. Investment Focus
    • Iii. Industry Overview
  • 320. Stem Cells Companies In Different Countries With Their Year Of Establishment, Accreditation And Stem Cells Banking Storage Price Structure
    • A. Industry Activities
    • Mergers/Acquisitions/Agreements/Patents Grants/Joint Ventures/Etc
    • New Culture Dish Overcomes The Limitations In Human Embryonic Stem Cell Research
    • Stem Cell Therapy A Major Role For Acute Lung Damage In Mice
    • New Approach In Medical Application Of Resourceful And Protected Pluripotent
    • Stem Cells For Engendering
    • Regenerative Stem Cell Treatments With Patients Having Congestive
    • Heart Failure Bioheart Therapies
    • Stem Cell Modulator Pipeline With Acquisition Of Fate Therapeutics
    • With Verio Therapeutics
    • Sru Biosystems Announces Introduction Of Bind(R) Scanner For Primary And Stem Cell Applications
    • New Progress Directed To A Get Through Process For Extended
    • Medical Application Of Mature Stem Cells
    • Agreement For Patent And Cultivation Of Pluripotent Stem Cells
    • Application On Chemokine Technology To Increase Efficacy Of Tissue-Specific
    • Stem Cell Homing In Copd Treatment
    • Testing Of Retinal Pigment From Human Parthenogenetic Stem Cells
    • Augmentation Feature Help Stem Cell Growth: Regeneration
    • Adult Allogeneic Mesenchymal Stem Cells Treatment For Stroke From
    • Stemedica Cell Technologies, Inc
    • Stem Cell Manufacturing For Stroke And Clinical Trial From Reneuron Group Plc
    • Patent Grand For Pluripotent Rat Stem Cells And Genetically Engineered
    • Rats For Stemcells, Inc
    • Stem Cells Build New Blood Vessels For The Treatment Peripheral Arterial Disease
    • Stem Cells Employed In Treatment Of Peripheral Arterial Disease
    • Proprietary Adult Stem Cell Lines Formation
    • The Synthemax(Tm) Surface For Scalable Growth Of Human Embryo Developed By
    • Geron Corporation And Corning Incorporated
    • Stem Cell Innovations To Offer Agennix The Research And Assay Services
    • Cardiac Stem Cell Therapy Presentation - Bmt Tandem Meet By Osiris Therapeutics
    • Stem Cell Therapy For Cardiac Diseases
    • Effective Use Of Proprietary Stem Cells In The Treatment Of Cirrhosis Of The Liver
    • Regenocyte Effectively Cures Cardiomyopathy Patient Using
    • Individual Adult Stem Cells
    • Limbs With Peripheral Arterial Disease Can Be Saved By Using Adult Stem Cells
    • Gamida Cell Ltd. Continuation Of Research On Stemex(R), A Cord Blood
    • Stem Cell Product, For Leukemia And Lymphoma
    • Bioheart’s Innovation Of First Fda Grant Clinical Trial To Test Congestive
    • Heart Failure For Gene-Modified Stem Cell Therapy
    • Fate Therapeutics Gets Grant Of First U.S. Copyright For Induced
    • Pluripotent Stem Cell Expertise
    • Stem Cells In Drug Discovery And Development
    • Stem Cell Therapy International Corp. Completely Amalgamated
    • With Histostem, Co., Ltd
    • Cancer Stem Cell Theories
    • Lost Vision Restored - Thanks To Umbilical Stem Cell Therapies
    • India The Next Potential Stem Cell Market – Cordlife
    • Regenerative Medicine Gets A Backup With Stem Cell Technology
    • Romania Starts Its Earliest Stem Cell Friendly Case
    • New Cord Blood Therapy! A New Ray Of Hope For Many Thalassemia Affected Patients
    • Florida University Scientists Discover That Blood Stem Cells Can Be
    • Changed To Visualization Cells
    • Dissimilarity Established Between Embryonic Stem Cells And Reprogrammed Skin Cells
    • Applications Invited For Post-Doc In Stem Cell Biology
    • (Molecular Biology/Cell Biology) In Bonn
    • 'Bush’s Stem Cell Restrictions To Go' Says President Obama
    • Obama To Lift The Ban Imposed By Bush On Embryonic Stem Cell Research
    • Initial Stem Cell Test Granted By Fda
    • Enhanced Blood Transfusion Supplies With Advent Of Stem Cells
    • Stem Cells Being Used To Perform Efficiency And Toxicity Screening Of Compounds
    • B. Market Trends
    • Stem Cell Treatment To Cure Diabetes
    • Revolutionary Stem Cell Remedy Reinstates Sight
    • Ucla Study Reveals The Use Of Stem Cells To Destroy Hiv
    • Stem Cells Capable Of Assisting Angina Patients
    • Agreement Sketching Out Moral Approach To Stem Cell Planned
    • Hottest Developments In Stem Cells Treatments
    • Embryonic Stem Cells Study Being Turned Into A Contentious Discussion
    • Adult Stem Cells Growing To Be A Hopeful Market
    • Human Experimental Test Of Stem Cell Based Medicine
    • Stem Cells Capable Of Reinstating Misplaced Brain Tasks
    • Growing Heart Valves From Stem Cells
    • Stem Cell Treatment Could Possibly Work In Opposition To Brain Inflammation
    • Resourceful Stem Cells Discovered In Amniotic Fluid
    • Stem Cell Progress Being Hit By Traditionalist
    • C. Industry Leaders
    • Aastrom Biosciences, Inc
    • Advanced Cell Technology, Inc
    • Bioheart, Inc
    • Cell Therapeutics, Inc
    • Sigma-Aldrich, Co
    • Stem Cell Innovations, Inc
    • Viacord
    • Cells4life, Ltd
    • Sanofi Aventis
    • Cryocord Sdn. Bhd
  • 321. Global List Of Key Companies In Stem Cell Industry
    • D. Stem Cells And Technologies – A Look A Head!!
    • E. Key Company Profiles
    • North America
    • Aastrom Biosciences, Inc
    • Acorda Therapeutics, Inc
    • Advanced Cell Technology, Inc
    • Affymetrix, Inc
    • Alpha Cord, Inc
    • Angioblast Systems, Inc
    • Bioheart, Inc
    • Cell Therapeutics, Inc
    • Corcell, Inc
    • Cord Blood Registry
    • Cryolife, Inc
    • Genzyme Corp
    • Millipore Corporation
    • Neostem, Inc
    • Osiris Therapeutics, Inc
    • Sigma-Aldrich, Co
    • Spectrocell, Inc
    • Stem Cell Innovations, Inc
    • Stem Cells, Inc
    • Stemlifeline Sciences, Inc
    • Thermo Fisher Scientific, Inc
    • Viacell, Inc
    • Viacord
    • Vital Therapies, Inc
    • Stem Cells Therapeutics, Corp
    • Stemcell Technologies, Inc
    • Europe
    • Cells4life, Ltd
    • Ge Healthcare
    • Reneuron Group Plc
    • Uk Stem Cell Bank
    • Boehringer Ingelheim, Gmbh
    • Sanofi Aventis
    • Cryo-Save, Ag
    • Asia-Pacific
    • Reliance Life Sciences
    • Cryocord Sdn. Bhd
    • Cordlife Pte., Ltd
    • Theravitae Co. Ltd
    • Iv. Industry Company Database
    • V. Appendix
    • A. Research Focus
    • B. About Axis Research Mind
    • C. Disclaimer
    • D. Feedback